Treace Medical Concepts, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Treace Medical Concepts, Inc. (TMCI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 15.39 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 15.11M shares, a 2.50% increase year-over-year.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 14.74M shares, a 29.28% increase year-over-year.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 11.40M shares, a 29.51% increase year-over-year.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 8.80M shares, a 18.71% increase year-over-year.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 13.37M shares, a 9.75% increase from fiscal 2024.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.18M shares, a 39.46% increase from fiscal 2023.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.74M shares, a 12.77% increase from fiscal 2022.
- Treace Medical Concepts, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 7.75M shares, a 3.37% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 15.39M shares 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | 15.11M shares 10-Q · filed 2026-05-08 | ||||
| 2025-12-31 | 13.37M shares 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | 14.53M shares 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 14.18M shares 10-Q · filed 2026-08-07 | ||||
| 2025-03-31 | 14.74M shares 10-Q · filed 2026-05-08 | ||||
| 2024-12-31 | 12.18M shares 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | 11.95M shares 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 10.36M shares 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | 11.40M shares 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | 8.74M shares 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | 8.79M shares 10-Q · filed 2024-11-05 | ||||
| 2023-06-30 | 8.64M shares 10-Q · filed 2024-08-06 | ||||
| 2023-03-31 | 8.80M shares 10-Q · filed 2024-05-07 | ||||
| 2022-12-31 | 7.75M shares 10-K · filed 2024-02-27 | ||||
| 2022-09-30 | 7.71M shares 10-Q · filed 2022-11-09 | ||||
| 2022-06-30 | 7.66M shares 10-Q · filed 2022-08-10 | ||||
| 2022-03-31 | 7.42M shares 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | 7.49M shares 10-K · filed 2023-03-08 | 7.46M shares 10-K · filed 2022-03-04 | |||
| 2021-09-30 | 8.86M shares 10-Q · filed 2021-11-04 | ||||
| 2021-06-30 | 8.50M shares 10-Q · filed 2021-08-05 | ||||
| 2021-03-31 | 15.30M shares 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | 15.48M shares 10-K · filed 2023-03-08 | ||||
| 2019-12-31 | 14.88M shares 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |